Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

BioGend Therapeutics Co., Ltd. (6733) Stock Price & Analysis

6733 Stock Chart & Stats

NT$21.00-NT$0.50(-2.33%)
At close: 12:30 AM EST
TWD 22.5TWD 25TWD 27.5Aug 10Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2
Day’s Range
TWD 20.15 - TWD 21.00
52-Week Range
TWD 20.15 - TWD 41.87
Previous Close
TWD 21.50
Volume
N/A
Average Volume (3M)
56.33K
Market Cap
TWD 2.82B
Enterprise Value
TWD 2.51B
Total Cash (Recent Filing)
TWD 849.79M
Total Debt (Recent Filing)
TWD 4.76M
Price to Earnings (P/E)
―
Beta
0.40
Next Earnings
Mar 02, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

6733 FAQ

What was BioGend Therapeutics Co., Ltd.’s price range in the past 12 months?
BioGend Therapeutics Co., Ltd. lowest stock price was TWD 20.15 and its highest was TWD 41.87 in the past 12 months.
What is BioGend Therapeutics Co., Ltd.’s market cap?
BioGend Therapeutics Co., Ltd.’s market cap is TWD 2.82B.
When is BioGend Therapeutics Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were BioGend Therapeutics Co., Ltd.’s earnings last quarter?
BioGend Therapeutics Co., Ltd. released its earnings results on Nov 05, 2026. The company reported -TWD 0.167 earnings per share for the quarter.
Is BioGend Therapeutics Co., Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does BioGend Therapeutics Co., Ltd. pay dividends?
BioGend Therapeutics Co., Ltd. does not currently pay dividends.
What is BioGend Therapeutics Co., Ltd.’s EPS estimate?
BioGend Therapeutics Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioGend Therapeutics Co., Ltd. have?
BioGend Therapeutics Co., Ltd. has 134,316,020 shares outstanding.
What happened to BioGend Therapeutics Co., Ltd.’s price movement after its last earnings report?
BioGend Therapeutics Co., Ltd. reported an EPS of -TWD 0.167 in its last earnings report. Following the earnings report the stock price went down -1.149%.
Which hedge fund is a major shareholder of BioGend Therapeutics Co., Ltd.?
Currently, no hedge funds are holding shares in TW:6733
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology